Quotient (QTNT) Prices 17.647M Upsized Common Offering at $4.25/Sh

Pre-Open Movers 09/10: (VRTU) (RH) (NAV) Higher; (STSA) (PRPL) (NKLA) Lower (more...)

Today's Pre-Open Movers

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) 80% LOWER; announced topline results from its Phase 3 EMERGE efficacy trial of STS101 (dihydroergotamine (DHE) nasal) powder as an acute treatment for migraine. Although topline data showed numerical differences in favor of STS101 3.9 mg and 5.2 mg versus placebo on the pre-specified co-primary endpoints of freedom from pain and freedom from most bothersome symptom (from among photophobia, phonophobia and nausea) at two hours post-administration, these differences did not achieve statistical significance for either dosage strength. Both dosage strengths of STS101 did, however,... More

After-Hours Movers 09/09: (RMTI) (RH) (SLQT) Higher; (PRPL) (GME) (BIGC) Lower (more...)

Today's After-Hours Movers

Rockwell Medical, Inc. (Nasdaq: RMTI) 32.5% HIGHER; entered into an exclusive license agreement with Jeil Pharmaceutical Co., Ltd. (Jeil), for the rights to commercialize Triferic (ferric pyrophosphate citrate) in South Korea.

Purple Innovation, Inc. (NASDAQ: PRPL) 14.7% LOWER; announced the launch of an underwritten secondary public offering of 11,826,087 shares of its Class A common stock to be sold by InnoHold, LLC (the "Selling Stockholder").

RH (NYSE: RH)... More

Quotient (QTNT) Announces Proposed $60M Common Share Offering

Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the Company intends to commence an underwritten public offering of $60 million of its ordinary shares. All of the ordinary shares to be sold in the offering will be offered by the Company. In... More